Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Wayland Signs 9,000 kgs Supply Agreement with Cannamedical for Export to Germany

Wayland Signs 9,000 kgs Supply Agreement with Cannamedical for Export to GermanyToronto and Munich-based Wayland Group, formerly MariCann (CSE:WAYL) (OTCQB:MRRCF) agreed to supply Cannamedical Pharma Gmbh, a licensed, privately owned importer and distributor of cannabis in Germany to over 2,200 pharmacies, with a minimum of 9,000 kilograms of EU-GMP certified cannabis flowers over a three year term.

The companies have completed mandatory quality assurance and control audits and have scheduled the first shipment in December of 2018.

“The decision we made…to move to EU-GMP standards for all production, including cannabis flowers, followed by certification…this year by the German Health Authorities, provides Wayland with the opportunity to move a significant amount of product, in this case 9,000 kilograms to Germany, said Ben Ward, CEO of Wayland.

“We’re proud to be one of six companies worldwide…who exceed EU-GMP standards for dry cannabis flowers. This agreement will provide meaningful revenue and profit to the Company over the next three years as we build a sustainable business,” Ward continued.

“Being able to meet the exponentially growing demand of our European client base strengthens our position as the largest independent and privately-owned cannabis distributor in Germany. Cannamedical will formally introduce its CannaSativa®, CannaIndica® and Cannahybrid® product lines during next week’s German pain congress in Mannheim, Germany,” stated David Henn, CEO of Cannamedical.

Learn more about other exciting cannabis companies in the Cannin Report. Sign up for Cannin Free Access and subscribe to the Cannin Chronicle. We’ll help you determine which cannabis companies to invest in.

Source Wayland press release

Wayland Signs 9,000 kgs Supply Agreement with Cannamedical for Export to Germany

About Cannin Investment Group: Your Pot Stocks Experts

Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in pot stocks? No! This is the perfect time to invest.

Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.

Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?

Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • 108% Backtested since 2012

We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best pot stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Penny Hemp Stocks